Christopher Posner, President & CEO, Region U.S.

Chris Posner is LEO Pharma’s Executive Vice President of Region U.S. and President & CEO of LEO Pharma Inc. – the U.S. affiliate. Chris joined LEO Pharma from R-Pharm U.S., a specialty pharmaceutical start-up focused on oncology and chronic immune diseases, where he was Head of Worldwide Commercial Operations.
Chris has extensive experience in the healthcare industry including biologic medicines as well as immunology and led the commercialization of national and global brands at Bristol-Myers Squibb, Pfizer, Wyeth, Endo Pharmaceuticals and Merck.
Before joining the pharmaceutical industry, Chris was a senior economic consultant at Wharton Econometric Forecasting Associates. Chris earned his MBA from Fuqua School of Business, Duke University and his Bachelor of Arts in Economics from Villanova University.


Judit H. Nyirady, M.D., VP, Medical Strategy & Scientific Affairs

Dr. Judit H. Nyirady is LEO Pharma Inc’s Vice President of Medical Strategy & Scientific Affairs. Prior to joining LEO Pharma, Dr. Nyirady was the interim Medical Unit Head of Dermatology & Immunology at Novartis Pharmaceuticals. Additionally, she served as the Executive Director of U.S. Clinical Development and Medical Affairs, and was the former Global Brand Medical Director of Dermatology. Prior to joining Novartis, Dr. Nyirady worked at Johnson & Johnson Consumer Products Worldwide in Medical Affairs, Dermatology.
Dr. Nyirady is a dermatologist, holds a MBA from Cornell University, Johnson Graduate School of Management and obtained her medical diploma in Hungary from Albert Szent-Györgyi Medical University. Dr. Nyirady also serves as an Adjunct Assistant Professor in Dermatology at Rutgers University in Newark, New Jersey.

Keith Bernius, CFO & VP, Business Operations

Keith Bernius is LEO Pharma Inc’s CFO & Vice President of Business Operations. Prior to joining LEO Pharma, Keith was the Vice President of Finance and Treasurer of Altegrity Inc. where he was responsible for global treasury, investor relations, risk management, enterprise FP&A and real estate. Prior to Altegrity, he worked at Alpharma Pharmaceuticals for seven years serving in both corporate finance and divisional roles with his last position at Alpharma as Vice President, Finance and Pharmaceuticals CFO.
Keith holds a Bachelor of Science in Accounting from Manhattan College and is a Certified Public Accountant.

Domenic Verroca, VP, Patient Market Access & Public Affairs

Domenic Verroca, Ph.D., is LEO Pharma Inc’s Vice President of Market Access & Public Affairs. Domenic joined LEO Pharma after serving as Vice President of Market Access at Galderma. Prior to Galderma, Domenic worked at Sanofi for over 11 years in positions of increasing responsibility. His last position at Sanofi was as Vice President of U.S. Market Access, which he held for more than six years. Prior to Galderma, he worked for Pharmacia and Johnson & Johnson Health Care Systems Inc.
Domenic holds a Bachelor of Arts in Economics and Geography from Coventry University in England, a Master of Arts degree in International Affairs from Drew University and a Ph.D. in Management from the University of Pittsburgh.


Doreen V. Morgan, VP, Regulatory Affairs & Quality

Dr. Doreen V. Morgan is LEO Pharma Inc.’s Vice President of Regulatory Affairs & Quality. Dr. Morgan has more than 25 years of experience in the pharmaceutical industry including extensive knowledge of U.S. FDA regulatory requirements, global regulatory strategy and regulatory leadership of global trials (U.S., EU, Japan). Prior to joining LEO Pharma, Dr. Morgan held the position of Executive Director of Regulatory Affairs at Daiichi Sankyo for more than eight years. Dr. Morgan also worked at Forest Laboratories as the Senior Director of Regulatory Affairs, held the position of Director of U.S. Regulatory at Knoll Pharmaceutical Company and positions of increasing responsibility at Hoffman-La Roche.
Dr. Morgan holds a Doctor of Pharmacy and a Masters of Science in Clinical Pharmacy from St. John’s University.

Tiffany L. Christian, Director, Legal

Tiffany L. Christian is LEO Pharma Inc.’s Director of Legal. Tiffany oversees all legal activities in the US and has over 15 years experience in the pharmaceutical industry.
Prior to joining LEO Pharma, Tiffany was Counsel at Warner Chilcott where she provided general counsel and advice, with a focus on the advertising and promotion of products. Prior to Warner Chilcott, Tiffany was a Commercial Litigation Associate at DLA Piper where she concentrated on product liability litigation. Prior to joining DLA Piper, Tiffany was a Litigation Associate at Sills Cummis & Gross P.C.
Tiffany holds a Juris Doctor from Georgetown University Law Center and a Bachelor of Arts from Cornell University.

John Tomasello, VP & Head, Human Resources and Communications

John Tomasello is LEO Pharma Inc’s Vice President & Head of Human Resources and Communicatons. John is an HR executive with more than 20 years of multinational human resources experience, including over 15 years within the healthcare industry.
Prior to joining LEO Pharma, John was Vice President, Human Resources at Mallinckrodt Pharmaceuticals where he was responsible for the company’s international, multibillion dollar specialty biopharmaceuticals portfolio (rare disease and hospital). Prior to Mallinckrodt, John held global, and U.S. HR leadership roles at Baxter International, The Valspar Corporation and Novartis.
John holds a Master of Science in Human Resources and a Bachelor of Science in Marketing from Rutgers University.

John Bujnoski, VP, Global Marketing Eczema

John Bujnoski is LEO Pharma’s Vice President of Global Marketing for the Eczema portfolio. John has more than 25 years of global commercial experience and has led product teams that drive business results in the U.S. and globally. His experience includes senior level assignments in global organizations including Sandoz, Pfizer, Wyeth Pharmaceuticals and Merck. In addition to extensive U.S. experience, he has lived and worked in Italy and Germany.
John holds a Master of Business Administration from Florida State University and a Bachelor of Science in Finance from University of Florida


Brian Mulnix, VP, Marketing

Brian Mulnix is LEO Pharma Inc’s Vice President of Marketing. Prior to joining LEO Pharma, Brian was Head of Strategy and Business Development at Sun Pharmaceutical Industries where he negotiated pharmaceutical in-licensing and commercialization partnerships for U.S. and global markets. Previous to Sun Pharmaceutical Industries, Brian was Vice President U.S. Marketing at Galderma. Brian was also the Xeljanz Commercial Team Leader, Enbrel Global Asset Leader and Enbrel U.S. Marketing Team Lead positions at Pfizer. Prior to Pfizer, Brian held global and regional roles at Endo Pharmaceuticals and Merck.
Brian received his MBA from the University of Michigan - Ross School of Business and his Bachelor of Science in Applied Economics from the University of Minnesota.


Gary Branch, VP, Sales

Gary Branch is LEO Pharma Inc’s Vice President of Sales. Gary has more than 25 years of commercial experience in the pharmaceutical industry. Most recently, Gary served as the Vice President of Sales at Lexicon Pharmaceuticals, a start-up bio-pharm company, where he built the entire sales and sales support organization in preparation for the company’s first commercial launch. Prior to joining Lexicon, Gary spent many years at both Novartis Pharmaceuticals and GlaxoSmithKline Pharmaceuticals, where he held commercial positions of increasing responsibility in Marketing, Sales, and Managed Care. Gary has deep breadth and depth in Oncology and General Medicines. He has worked in multiple countries and at the global level.
Gary received his MBA from the University of Michigan Business School and his Bachelor of Science in Engineering from the United States Military Academy at West Point, New York